86 related articles for article (PubMed ID: 25436812)
41. Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery.
Kondo M; Yokoyama T; Fukui T; Yoshioka H; Yokoi K; Nagasaka T; Imaizumi K; Kume H; Hasegawa Y; Shimokata K; Sekido Y
Lung Cancer; 2005 Dec; 50(3):385-91. PubMed ID: 16140420
[TBL] [Abstract][Full Text] [Related]
42. Molecular signatures of lung cancer--toward personalized therapy.
Herbst RS; Lippman SM
N Engl J Med; 2007 Jan; 356(1):76-8. PubMed ID: 17202459
[No Abstract] [Full Text] [Related]
43. Prevalence of mutation in the epidermal growth factor receptor gene in Chinese patients with non-small cell lung cancer.
Jiang B; Zhu ZZ; Liu F; Hou LF; Gu J; Chen E; Tzeng CM; Zhu G
Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):635. PubMed ID: 17051955
[No Abstract] [Full Text] [Related]
44. Epidermal growth factor receptor overexpression: the importance of context.
Carbone DP
J Clin Oncol; 2003 Dec; 21(23):4268-9. PubMed ID: 14581439
[No Abstract] [Full Text] [Related]
45. [Analysis of mutation feature at exon 19 of epidermal growth factor receptor gene in non-small cell lung cancer from Chinese patients].
Wang HY; Luo H; Zhao YM; Tang L; Yi XH; Zhou CC
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):405-6. PubMed ID: 19031721
[No Abstract] [Full Text] [Related]
46. What is the true prevalence of EGFR mutations in India?
Jiwnani S; Karimundackal G; Pramesh CS; Prabhash K
Lung Cancer; 2011 Dec; 74(3):549. PubMed ID: 21996090
[No Abstract] [Full Text] [Related]
47. Histological analysis of epidermal growth factor receptor gene mutation and clinical characteristics of advanced peripheral lung cancer.
Jin JJ; Xu LX; Zhang D; Wang CX; Fan Z; Xu TT; Wang S; Huang Y
J Biol Regul Homeost Agents; 2020; 34(6):2079-2082. PubMed ID: 33190471
[No Abstract] [Full Text] [Related]
48. Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain.
Cooper AJ; Gainor JF
J Clin Oncol; 2022 Mar; 40(7):693-697. PubMed ID: 35072488
[No Abstract] [Full Text] [Related]
49. Intronic boundary mutation rs430397 cannot affect alternate splicing and is an indecisive risk factor for non-small cell lung cancer.
Zhu X; Fan W; Li D
Chest; 2012 Dec; 142(6):1691-1692. PubMed ID: 23208355
[No Abstract] [Full Text] [Related]
50. [Ribonucleotide reductase and non-small cell lung cancer].
Hsu NY; Lee H; Cheng YW; Yen Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):619-23. PubMed ID: 23092586
[No Abstract] [Full Text] [Related]
51. Sharing new approaches to translational research in non-small cell lung cancer.
O'Brate A; Tarón M; Gandara D; Rosell R
Oncologist; 2000; 5(6):514-9. PubMed ID: 11110605
[No Abstract] [Full Text] [Related]
52. Isolated glycerol kinase deficiency and Fanconi anemia.
Sjarif DR; Révész T; de Koning TJ; Duran M; Beemer FA; Poll-The BT
Am J Med Genet; 2001 Mar; 99(2):159-60. PubMed ID: 11241478
[No Abstract] [Full Text] [Related]
53. Red cell aplasia.
Ozsoylu S
Eur J Pediatr; 1994 Jan; 153(1):54. PubMed ID: 8313928
[No Abstract] [Full Text] [Related]
54. Commentary: How to "spot" a leopard: It's in the genes.
Lazar JF
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e82-e83. PubMed ID: 32113723
[No Abstract] [Full Text] [Related]
55. Serial Cancer Development Three Times in a Patient with Fanconi Anemia.
Yanagisawa K; Horiuchi T; Matsuo A; Kuraishi H; Satomi H; Ito I; Noguchi T; Sekiguchi N; Kanda S; Koizumi T
Case Rep Oncol; 2021; 14(2):1168-1174. PubMed ID: 34703432
[TBL] [Abstract][Full Text] [Related]
56. Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization.
Schueler J; Tschuch C; Klingner K; Bug D; Peille AL; de Koning L; Oswald E; Klett H; Sommergruber W
Cells; 2019 Jul; 8(7):. PubMed ID: 31323891
[TBL] [Abstract][Full Text] [Related]
57. Young male with fanconi anemia and EGFR-mutant non-small-cell lung cancer.
Cathcart-Rake E; Lopez-Chavez A
J Thorac Oncol; 2014 Nov; 9(11):e83-5. PubMed ID: 25436812
[No Abstract] [Full Text] [Related]
58. EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.
Dowell JE; Minna JD
Nat Clin Pract Oncol; 2006 Apr; 3(4):170-1. PubMed ID: 16596125
[No Abstract] [Full Text] [Related]
59. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
Nagai Y; Miyazawa H; Huqun ; Tanaka T; Udagawa K; Kato M; Fukuyama S; Yokote A; Kobayashi K; Kanazawa M; Hagiwara K
Cancer Res; 2005 Aug; 65(16):7276-82. PubMed ID: 16105816
[TBL] [Abstract][Full Text] [Related]
60. A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non-Small Cell Lung Cancer Patient.
Lee JS; Hur JY; Kim HJ; Lee KY; Kim WS
J Thorac Oncol; 2017 Nov; 12(11):e179-e181. PubMed ID: 29074208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
